AN OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND EFFICACY OF OMBITASVIR/PARITAPREVIR/RITONAVIR AND DASABUVIR WITH RIBAVIRIN IN ADULTS WITH GENOTYPE 1 AND OMBITASVIR/PARITAPREVIR/RITONAVIR WITH RIBAVIRIN IN ADULTS WITH GENOTYPE 4 CHRONIC HEPATITIS C VIRUS INFECTION AND DECOMPENSATED CIRRHOSIS (TURQUOISE-CPB)

Registry ID
M14-227
Source registry
HEALTH_CANADA
Status
Closed
Study type
INTERVENTIONAL
Sponsor
ABBVIE CORPORATION
Start date
2014-09-25
Completion date
2017-03-03
Last update
2014-08-13

Conditions

Related clinical trials

View on source registry